Group 1: Kratos Defense & Security Solutions, Inc. - Kratos Defense secured a $68.3 million deal for a hypersonic materials testing facility through the Defense Department's Industrial Base Analysis and Sustainment Program [1] - The company is recognized as a "terrific" stock by Jim Cramer, who suggests it is a good time to invest as the stock has come down a bit [1] Group 2: Novartis AG - Novartis recently shared topline data from the Phase 3 REPLENISH trial of Cosentyx in patients with polymyalgia rheumatica [2] - Novartis shares rose 0.2% to settle at $131.64 on Thursday [4] Group 3: IonQ, Inc. - IonQ shares rose 37.75% year to date, closing at $59.37, following news of potential equity stakes from the Trump administration in quantum-computing firms [2] - The stock gained 7.1% on Thursday [4] Group 4: Qfin Holdings, Inc. - Qfin Holdings reported worse-than-expected second-quarter results on August 14 [3] - The stock gained 1.3% to settle at $26.51 on Thursday [4] Group 5: Alibaba Group Holding Limited - Jim Cramer recommends sticking with Alibaba Group, indicating a positive outlook for the company [3]

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by officers and directors of BioVie Inc., urging shareholders to contact the firm to discuss their rights and possible legal actions [1][2]. Group 1: Shareholder Rights and Legal Options - Shareholders who acquired BioVie stock on or before December 7, 2022, may seek corporate governance reforms, return of funds, court-approved financial incentives, or other benefits [2]. - The firm operates on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees [2]. Group 2: Importance of Shareholder Participation - Active shareholder involvement can lead to improved company policies, practices, and oversight, ultimately enhancing shareholder value [3]. Group 3: Firm's Background and Experience - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors [4].

Core Insights - Horizon Aircraft has been awarded a non-dilutive grant from the INSAT program to fund the CRYSTAL project, which aims to develop an all-weather eVTOL propulsion system [1] - The total estimated expenditure for the CRYSTAL project is $10.5 million, with Horizon Aircraft receiving $2.0 million in grant proceeds [1] Company Overview - Horizon Aircraft is an advanced aerospace engineering company focused on developing hybrid eVTOL aircraft [1] - The company is collaborating with the Flight Centre of Excellence and the University of Toronto for the CRYSTAL project [1]

Core Viewpoint - Bleichmar Fonti & Auld LLP is investigating Grindr Inc.'s board of directors and majority stockholders for potential breaches of fiduciary duties related to a proposed take-private transaction that may disadvantage minority shareholders [1][5]. Group 1: Investigation Details - The investigation focuses on majority stockholders James Fu Bin Lu and George Raymond Zage, III, who are proposing a transaction to take Grindr private, potentially cashing out minority shareholders while retaining their ownership [3][5]. - Lu and Zage have secured debt financing of up to $1 billion, contingent on the deal being at or above $15 per share [3]. - There is no indication that the final deal will require a majority-of-the-minority stockholder vote, raising concerns about the effectiveness of the special committee appointed by the company [4]. Group 2: Legal Options for Shareholders - Current shareholders of Grindr are encouraged to seek additional information and may have legal options available to them [2][6]. - BFA Law operates on a contingency fee basis, meaning shareholders will not incur court costs or litigation expenses [6].

Accessibility StatementSkip Navigation WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? HONG KONG, Oct. 24, 2025 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC), a diversified investment holding company with subsidiaries engaged in logistics, warehousing, and consulting services, has announced its unaudited financial highlights for the first two quarters of 2025, showing remarkable year-over-year growth. For the first quarter of 2025, the Group recorded a 138% increase in revenue and a 158% increase in gross ...

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Guess?, Inc.’s (NYSE: GES) board of directors and executive officers for potential breaches of their fiduciary duties to shareholders in connection with its pending sale to Authentic Brands Group LLC (“Authentic”) for $16.75 per share. If you are a current shareholder of Guess, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/guess-in ...

PresentationYasuaki OkadaGeneral Manager of IR Group Hi, everybody. I'm Okada, General Manager of IR Group, and I'll be the host for today's webinar. Thanks for joining us, and we truly appreciate your time and interest. Today's webinar is all about next-generation marine fuel, business opportunities arising from this transition and NYK strategy in this transition. We hope you will find the session informative. First, I'd like to introduce our speaker, Mr. Rokuroda, General Manager of Next-Generation Fuel B ...

With a market cap of $20.1 billion, Corpay, Inc. (CPAY) is a global corporate payments leader that helps businesses and consumers manage expenses efficiently through modern payment solutions. With over 800,000 clients worldwide, Corpay simplifies vehicle, travel, and vendor payments, driving time and cost savings across industries. The Atlanta, Georgia-based company is expected to announce its fiscal Q3 2025 results after the market closes on Wednesday, Nov. 5. Ahead of this event, analysts expect Corpay ...

My last coverage of Crispr Therapeutics (NASDAQ: CRSP ) and Intellia Therapeutics (NASDAQ: NTLA ) was published in May 2025 . At the time, gene therapy stocks were suffering from regulatory uncertainties, potential pricingOriginally a Biologist, M.Sc in Biomedicine, PhD in Bioengineering, with +20 years experience in the research and development of novel Cell & Gene Therapies (CGT) tackling several clinical needs. As an investor, I have been utilising my background in life sciences to assess the potential o ...

The cybersecurity company CrowdStrike Holdings Inc. (NASDAQ: CRWD) recently saw record attendance at its Fal.Con 2025 conference, and it unveiled a major update to its Falcon platform. ...